Product
Antithrombin III
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
Multinational, Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 InfectionStatus: Completed, Estimated PCD: 2022-09-27